Novel Treatments for Autism - Antonio Hardan MD, Stanford University @Synchrony2020

Antonia Hardan MD is a Professor of Psychiatry and Behavioral Sciences - Child and Adolescent Psychiatry at Stanford Hospital and ClinicsLucile Packard Children's Hospital.

His research expertise is in the neurobiology of autism and in the development of innovative treatment. He served as a principal investigator on numerous projects examining the neurobiology of autism and assessing the effectiveness of a wide range of interventions. He is the recipient of an R01 (MH083972) “A Neuroimaging Study of Twin Pairs with Autism” and a pilot grant from Autism Speaks examining the effectiveness of pivotal response group treatment for parents of young children with autism. He has completed several investigations aimed toward increasing our understanding of the pathophysiology of pervasive developmental disorders while applying multimodal imaging techniques.

Dr. Hardan has also led several clinical trials examining the effectiveness of novel interventions such as N-acetylcysteine and pivotal response group training in children with autism.

This talk was part of Synchrony 2020 Online Symposium - 'From Bench to Biopharma', organised by the The BRAIN Foundation in partnership with UC Davis MIND Institute and CalTech.

For more Synchrony 2020 talks and highlights:    • Synchrony Symposium 2020 - From Bench...  

🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

Synchrony https://synchronysymposium.com/ is the first and only international symposium on translational research in #autism, that brings together academia, #biotech, pharmaceutical companies and #venture partners from around the world with the mission to improve health and quality of life of people with #autismspectrumdisorder.

🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

The BRAIN Foundation https://brainfoundation.org/ is a 501c(3) non-profit. The founders of BRAIN envision a world where every child and adult on the autism spectrum is healthy, participates fully in education and employment, and has a better quality of life. It aims to catalyze research that results in evidence-based interventions for the disabilities associated with autism, and also results in better medical standard of care.

To accomplish this, it funds impactful research through #philanthropy and our network of partners in the venture, corporate, and grassroots community.